[
1. A. V. Raveendran, E. C. Chacko and J. M. Pappachan, Non-pharmacological treatment options in the management of diabetes mellitus, Eur. Endocrinol. 14 (2018) 31–39; https://doi.org/10.17925/EE.2018.14.2.31
]Search in Google Scholar
[
2. A. Hussain, O. B. Latiwesh, F. Ali, M. Y. G. Younis and J. A. Alammari, Effects of body mass index, glycemic control, and hypoglycemic drugs on serum uric acid levels in type 2 diabetic patients, Cureus 10 (2018) e3158; https://doi.org/10.7759/cureus.3158
]Search in Google Scholar
[
3. G. T. Chen, B. B. Yang, J. H. Chen, Z. Zhang, L. L. Zhu, H. S. Jiang, W. Yu, Y. Chen and Y. T. Dai, Pancreatic kininogenase improves erectile function in streptozotocin-induced type 2 diabetic rats with erectile dysfunction, Asian J. Androl. 20 (2018) 448–453; https://doi.org/10.4103/aja.aja_23_18
]Search in Google Scholar
[
4. L. Chen, S. E. Staubli, M. P. Schneider, A. G. Kessels, S. Ivic, L. M. Bachmann and T. M. Kessler, Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis, Eur. Urol. 68 (2015) 674–680; https://doi.org/10.1016/j.eururo.2015.03.031
]Search in Google Scholar
[
5. R. S. Calabrò, G. Polimeni and P. Bramanti, Current and future therapies of erectile dysfunction in neurological disorders, Rec. Pat. CNS Drug Discov. 6 (2011) 48–64.
]Search in Google Scholar
[
6. S. J. Flora, Role of free radicals and antioxidants in health and disease, Cell. Mol. Biol. 53 (2007) 1–2.
]Search in Google Scholar
[
7. J. T. Coyle and P. Puttfarcken, Oxidative stress, glutamate, and neurodegenerative disorders, Science 262 (1993) 689–695.
]Search in Google Scholar
[
8. M. C. Vogt and J. C. Brüning, CNS insulin signaling in the control of energy homeostasis and glucose metabolism – from embryo to old age, Trends Endocrinol. Metab. 24 (2013) 76–84; https://doi.org/10.1016/j.tem.2012.11.004
]Search in Google Scholar
[
9. G. D. Calderon, N. Osnaya Brizuela, M. Ortiz Herrera, O. H. Juarez, A. Valenzuela Peraza and G. Barragan Mejía, Effect of an antiviral and vitamins A, C, D on dopamine and some oxidative stress markers in rat brain exposed to ozone, Arch. Biol. Sci. Belgrade 65 (2013) 1371–1379; https://doi.org/10.1186/s12868-018-0474-4
]Search in Google Scholar
[
10. D. Calderón Guzmán, N. Osnaya Brizuela, M. Ortíz Herrera, E. Hernandez Garcia, G. Barragan Mejía, H. Juarez Olguín, A. Valenzuela Peraza, J. Attilus and N. Labra Ruiz, Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid, Acta Pharm. 66 (2016) 443–448; https://doi.org/10.1515/acph-2016-0027
]Search in Google Scholar
[
11. F. Bilotta and G. Rosa, Optimal glycemic control in neurocritical care patients, Crit. Care 16 (2012) 163–165; https://doi.org/10.1186/cc11521
]Search in Google Scholar
[
12. S. Ammon-Treiber, D. Stolze, H. Schroder, H. Loh and V. Hollt, Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model, Neuropharmacology 49 (2005) 1160–1169; https://doi.org/10.1016/j.neuropharm.2005.06.016
]Search in Google Scholar
[
13. J. H. Jhamandas, K. H. Harris, T. Petrov and K. H. Jhamandas, Activation of nitric oxide-synthesizing neurons during precipitated morphine withdrawal, Neuroreport 7 (1996) 2843–2846.
]Search in Google Scholar
[
14. G. D. Calderón, G. E. Hernández, M. G. Barragán, O. H. Juárez, G. J. Saldivar and R. N. Labra, Effect of morphine and lacosamide on levels of dopamine and 5-HIAA in brain regions of rats with induced hypoglycemia, Pak. J. Biol. Sci. 17 (2014) 292–296.
]Search in Google Scholar
[
15. S. P. Filippov, ATPase activity of rat brain microsomal and synaptosomal fractions in insulin hypoglycemia and its treatment with glucose, Probl. Endokrinol. (Moskow) 37 (1991) 52–54; https://doi.org/10.1134/S0022093006020062
]Search in Google Scholar
[
16. E. Mandosi, E. Giannetta, T. Filardi, M. Lococo, C. Bertolini, M. FAllarino, D. Gianfrilli, M. A. Venneri, L. Lenti, S. Morano and A. Lenzi, Endothelial dysfuntion markers as a therapeutic target for sildenafil treatment and effects on metabolic control in type 2 diabetes, Expert Opin. Ther. Target. 19 (2015) 1617–1622; https://doi.org/10.1517/14728222.2015.1066337
]Search in Google Scholar
[
17. C. E. Ramirez, H. Nian, Y. Chang, L. J. Gamboa, J. M. Luther, N. J. Brown and C. A. Shibao, Treatment with sildenafil improves insulin sensitivity in prediabetes: a randomized, controlled trial, JCEM 100 (2015) 4533–4540; https://doi.org/10.1210/jc.2015-3415
]Search in Google Scholar
[
18. F. G. Al-Amran, A. A. Zwain, N. R. Hadi and A. M. Al-Mudhaffer, Autonomic cerebral vascular response to sildenafil in diabetic patient, Diabetol. Metab. Syndr. 4 (2012) 2–8; https://doi.org/10.1186/1758-5996-4-2
]Search in Google Scholar
